Rhythm Pharmaceuticals RYTM
NASDAQ RYTM
$92.83 -0.58 (-0.62%)
At close: Oct 2, 2026 · 4:00 PM EDT

Rhythm Pharmaceuticals (RYTM) Return on Capital Employed [ROCE] (2017 - 2026)

Updated

Rhythm Pharmaceuticals' Return on Capital Employed [ROCE] was -63.45% in Q2 2026, up 7.45 percentage points from -70.90% a year earlier but down 8.33 percentage points from the prior quarter.

Analysis

Rhythm Pharmaceuticals (RYTM) Return on Capital Employed [ROCE] (2017 - 2026) Analysis & Trends

For FY2025, Return on Capital Employed [ROCE] at Rhythm Pharmaceuticals came in at -58.14%, up 49.36 percentage points from FY2024.

  • Return on Capital Employed [ROCE] shows a five-year change of +1.30 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Capital Employed [ROCE] was -107.49% in FY2024 (-46.53 pp), -60.96% in FY2023 (-4.30 pp), -56.66% in FY2022 (+22.48 pp) and -79.14% in FY2021 (-19.71 pp).
  • Quarterly Return on Capital Employed [ROCE] has moved between -112.49% (Q1 2024) and -44.21% (Q3 2021) over five years.
  • Compared with a year earlier, Return on Capital Employed [ROCE] has increased for six straight quarters, with an average year-over-year change of +14.82 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was Q4 2025 (a gain of 51.64 percentage points); the worst was Q1 2024 (a drop of 56.21 percentage points).
  • Per Business Quant data, RYTM's Return on Capital Employed [ROCE] in the three quarters before Q2 2026 was -55.12% (Q1 2026), -49.54% (Q4 2025) and -55.50% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 17.83%
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 17.92%
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 19.32%
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 9.54%
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 16.66%
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -5.97%
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 11.86%
10 Rhythm Pharmaceuticals 6.43 Bn 5.30 Bn 62.32 Mn -63.45%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -63.45%
Mar 31, 2026 -55.12%
Dec 31, 2025 -49.54%
Sep 30, 2025 -55.50%
Jun 30, 2025 -70.90%
Mar 31, 2025 -62.17%
Dec 31, 2024 -101.18%
Sep 30, 2024 -96.51%
Jun 30, 2024 -100.02%
Mar 31, 2024 -112.49%
Dec 31, 2023 -63.95%
Sep 30, 2023 -65.69%
Jun 30, 2023 -64.08%
Mar 31, 2023 -56.28%
Dec 31, 2022 -51.74%
Sep 30, 2022 -62.57%
Jun 30, 2022 -81.55%
Mar 31, 2022 -72.47%
Dec 31, 2021 -56.83%
Sep 30, 2021 -44.21%
API Access

Rhythm Pharmaceuticals Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=RYTM&period=max&api_key=YOUR_API_KEY